|
|
||||||||
LETTER |
Clinical Professor of Behavioral Medicine Midwestern University/Chicago College of Osteopathic Medicine Downers Grove, Ill
To the Editor: I was pleased to read the trichotillomania article by Joel R. Carr, DO, MPH, and coauthors (2006;106:647-652) in a past issue of JAOA—The Journal of the American Osteopathic Association. The article is a fine review of a condition that is troublesome but receives little attention.
For an alternative to selective serotonin reuptake inhibitors as a treatment option for trichotillomania, naltrexone hydrochloride is also effective. In fact, it is my first choice for patients with this clinical condition. I also suggest that, along with psychosocial therapy, every effort be made to involve patients diagnosed as having trichotillomania with the Trichotillomania Learning Center, Inc. In my experience, this resource has been helpful, especially for preadolescent and adolescent patients, and has been a significant adjunct to psychosocial therapy for patients and their families.
This article has been cited by other articles:
![]() |
G. Weissmann Back to Basic Science: Time for Another Flexner Report FASEB J, September 1, 2008; 22(9): 3097 - 3100. [Full Text] [PDF] |
||||
![]() |
J. R. Gimpel Getting "Beyond the Barriers" in Reforming Osteopathic Medical Education J Am Osteopath Assoc, July 1, 2007; 107(7): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |